The Liposonix® system is indicated for non-invasive waist circumference reduction.
Improper use of Liposonix may cause personal injury or damage to the system. See the User Manual for detailed directions, proper use, and full risk and safety information.
The Liposonix system is contraindicated for patients with less than 1.0 cm of subcutaneous adipose tissue beyond the system’s focal treatment depth in the treatment area, patients with a hernia in the treatment area, or patients who are pregnant or suspected to be pregnant. Additional product and safety information is available in the Liposonix System User Manual.
®/™ are trademarks of Valeant Pharmaceuticals International, Inc. or its affiliates. Any other product or brand names and logos are the property of their respective owners.
© 2015 Solta Medical, a division of Valeant Pharmaceuticals North America, LLC. All rights reserved.